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Introduction
Tumor PD-L1 expression is associated with increased
tumor-infiltrating lymphocytes (TILs) in diverse solid
tumors, including lung cancer. In addition, PD-L1 upre-
gulation in tumor and/or stromal immune cells has
been associated with increased clinical benefit to PD-1/
PD-L1 axis blockers. The significance of PD-L1 expres-
sion in different immune cell subpopulations at the
tumor microenvironment remains poorly understood.
Here, we measured PD-L1 protein specifically in tumor-
associated macrophages using objective methods and
analyzed its clinical significance in human lung cancer.
Methods
Using multiplexed quantitative immunofluorescence (QIF)
we measured the levels of PD-L1 protein (clone-E1L3N,
Cell Signaling technology) in 554 stages I-IV FFPE lung
carcinomas represented in two tissue-microarrays, one
from Yale University [YTMA79, n=204] and one from
Greece [YTMA140, n=350]. PD-L1 was measured using
multispectral QIF in CD68-positive cells (macrophages,
clone-KP1, DAKO) or in tumor cells (clone-AE1/AE3,
DAKO) based on fluorescence co-localization. The levels
of CD3 (T cells, clone-E272, Novus), CD8 (cytotoxic
T cells, clone-C8/144B, DAKO) and CD20 (B-lymphoctes,
clone-L26, DAKO) were also determined in the tumor
samples. Associations between the macrophage and tumor
PD-L1 levels, clinico-pathological variables and survival
were analyzed.
Results
In lung cancer samples, PD-L1 was detected in both
macrophages and tumor cells with a predominant
membranous staining pattern. Overall, the levels of PD-
L1 in the CD68+ population were lower than in tumor
cells in both cohorts (834 ± 314 AU vs 1113 ± 427 AU,
in the Yale cohort, P < 0.001; and 895 ± 451 AU vs
1069 ± 542 AU in the Greek set, P < 0.001). In both
collections, the macrophage and tumor PD-L1 signal
showed a positive non-linear association (Linear regres-
sion coefficient [R2]=0.311 in the Yale cohort and
R2=0.43 in the Greek collection). Using the median
score as cutpoint, elevated macrophage PD-L1 content
was significantly associated with high CD8+ and CD20+
cells in both cohorts. In addition, increased macrophage
PD-L1 signal was marginally associated with longer
overall survival in the Yale set (HR=0.676 [CI:0.450-
1.081], P=0.05), but not in the Greek group (HR=0.790
[CI:0.560-1.109], P=0.17).
Conclusion
PD-L1 is expressed in tumor-associated macrophages of
human lung carcinomas. The macrophage PD-L1 signal
is lower than in tumor epithelial cells and they show a
positive association. Elevated macrophage PD-L1 is pro-
minently associated with increased cytotoxic T lympho-
cytes and B cell infiltrates in lung tumors, but has
limited prognostic value. Further studies will be required
to evaluate the possible predictive role of PD-L1 expres-
sion in macrophages and other immune cell types.
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